Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Merck Capital Ventures Llc Insider Profile
4 Followers
Merck Capital Ventures Llc, Ten Percent Owner at HTG Molecular Diagnostics, holds 756.70K shares in HTG Molecular Diagnostics (Ticker: HTGMQ). Most recently, Merck Capital Ventures Llc Bought $167,343 shares of HTG Molecular Diagnostics on May 13, 2015 for an estimated value of 2.34M.
Merck Capital Ventures Llc has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Merck Capital Ventures Llc's holdings
Insider Roles
Ten Percent Owner
Roles that Merck Capital Ventures Llc holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 13, 2015 - May 13, 2016
Return:-79.10%
The most profitable trade made by Merck Capital Ventures Llc
Merck Capital Ventures Llc's Trading History
List of latest transactions for each holding click on a transaction to see Merck Capital Ventures Llc's performance on stock
You May Also Like
Merck Capital Ventures Llc insider profile FAQ
What is the percentage of profitable transactions made by Merck Capital Ventures Llc?
The percentage of profitable transactions made by Merck Capital Ventures Llc is ―.
What is the average return per transaction made by Merck Capital Ventures Llc?
The average return per transaction made by Merck Capital Ventures Llc is ―.
What stocks does Merck Capital Ventures Llc hold?
Merck Capital Ventures Llc holds: HTGMQ stocks.
What was Merck Capital Ventures Llc’s latest transaction?
Merck Capital Ventures Llc latest transaction was an Informative Buy of $2.34M.
What was Merck Capital Ventures Llc's most profitable transaction?
Merck Capital Ventures Llc’s most profitable transaction was an Informative Buy of HTGMQ stock on May 13, 2015. The return on the trade was -79.10%.
What is Merck Capital Ventures Llc's role in HTG Molecular Diagnostics?
Merck Capital Ventures Llc's role in HTG Molecular Diagnostics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.